Wei Tong
Impact in
-
- NF-κB Signaling Pathways
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Genomics, phytochemicals, and oxidative stress 3
- Natural product bioactivities and synthesis 2
- Phytochemical compounds biological activities 2
- Oncology 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Grace Y. Sun (3 shared papers)Mark Hannink (2 shared papers)J. Alan Diehl (2 shared papers)Xiaoyan Lu (4 shared papers)Kanaga Sabapathy (2 shared papers)Xiaohui Fan (4 shared papers)Zhongyi Hu (1 shared paper)Grace Y. Sun (1 shared paper)
- Journals
- Parasite (1 paper)Scientific Reports (1 paper)Cancer Cell (1 paper)RSC Advances (1 paper)Journal of Pharmaceutical and Biomedical Analysis (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Wei Tong
12 papers receiving 371 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 72
- Infectious Diseases 84
- Immunology 66
- Oncology 84
- Neurology 25
Countries citing papers authored by Wei Tong
This map shows the geographic impact of Wei Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Tong more than expected).
Fields of papers citing papers by Wei Tong
This network shows the impact of papers produced by Wei Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Tong. The network helps show where Wei Tong may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Tong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 106 | |
| 2 | 2012 | 75 | |
| 3 | 1995 | 50 | |
| 4 | 2016 | 32 | |
| 5 | 1995 | 26 | |
| 6 | 2016 | 23 | |
| 7 | 2015 | 21 | |
| 8 | 1999 | 18 | |
| 9 | 2021 | 9 | |
| 10 | 2015 | 8 | |
| 11 | 2015 | 6 | |
| 12 | 1994 | 3 |
About Wei Tong
Wei Tong is a scholar working on Molecular Biology, Oncology, Immunology, Infectious Diseases and Cancer Research, having authored 12 papers that have together received 377 indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (3 papers), Phagocytosis and Immune Regulation (2 papers), Natural product bioactivities and synthesis (2 papers), Phytochemical compounds biological activities (2 papers), Cancer-related Molecular Pathways (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), MicroRNA in disease regulation (1 paper) and COVID-19 diagnosis using AI (1 paper). The work is most often cited by research in Cancer Research (72 citations), Infectious Diseases (84 citations), Immunology (66 citations), Oncology (84 citations) and Neurology (25 citations). Wei Tong has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Grace Y. Sun, Mark Hannink, J. Alan Diehl, Xiaoyan Lu, Kanaga Sabapathy, Xiaohui Fan, Zhongyi Hu, Grace Y. Sun, Yue Gao and Qiangqiang Zhu. Their work appears in journals such as Parasite, Scientific Reports, Cancer Cell, RSC Advances and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.